Body mass index, immune status, and virological control in HIV-infected men who have sex with men

J Int Assoc Provid AIDS Care. 2013 Sep-Oct;12(5):319-24. doi: 10.1177/2325957413488182. Epub 2013 May 29.

Abstract

Background and aims: Prior cross-sectional studies have found inconsistent relationships between body mass index (BMI) and disease progression in HIV-infected individuals.

Methods: Cross-sectional and longitudinal analyses were conducted on data from a sample of 864 HIV-infected men who have sex with men (MSM) obtained from a large, nationally distributed HIV clinical cohort.

Results: Of the 864 HIV-infected MSM, 394 (46%) were of normal weight, 363 (42%) were overweight, and 107 (12%) were obese at baseline. The baseline CD4 count was 493 (standard error [SE] = 9), with viral load (log10) = 2.4 (SE = .04), and 561 (65%) were virologically suppressed. Over time, controlling for viral load, highly active antiretroviral therapy (HAART) adherence, age, and race/ethnicity, overweight and obese HIV-infected men possessed higher CD4 counts than that of normal weight HIV-infected men. Further, overweight and obese men possessed lower viral loads than that of normal weight HIV-infected men.

Conclusions: For HIV-infected MSM, in this longitudinal cohort study, possessing a heavier than normal BMI is longitudinally associated with improved immunological health.

Keywords: CD4; HIV/AIDS; body mass index; obesity; viral load.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Analysis of Variance
  • Anti-Retroviral Agents / therapeutic use
  • Antiretroviral Therapy, Highly Active
  • Body Mass Index*
  • CD4 Lymphocyte Count
  • Cross-Sectional Studies
  • HIV Infections / drug therapy
  • HIV Infections / epidemiology
  • HIV Infections / immunology*
  • HIV Infections / virology*
  • Homosexuality, Male / statistics & numerical data*
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Obesity / epidemiology
  • Obesity / immunology
  • Obesity / virology
  • United States / epidemiology
  • Viral Load

Substances

  • Anti-Retroviral Agents